Moomoo AI 已提取核心信息
On February 7, 2024, Eli Lilly and Company, a pharmaceutical giant, announced the successful completion of a significant debt offering. The company entered into an underwriting agreement with major financial institutions including BofA Securities, Barclays Capital, Citigroup Global Markets, Deutsche Bank Securities, and Mizuho Securities USA. The offering comprised a total of $6 billion in notes with varying maturities ranging from 2027 to 2064 and interest rates from 4.500% to 5.100%. The transaction closed on February 9, 2024, with Eli Lilly netting approximately $6.45 billion after underwriting discounts and before offering expenses. The notes were issued under an existing indenture dated February 1, 1991. Eli Lilly has the option to redeem the notes at specified redemption prices and terms. The company specified that in the event of a default, the principal amount of the notes may become immediately due and payable.
On February 7, 2024, Eli Lilly and Company, a pharmaceutical giant, announced the successful completion of a significant debt offering. The company entered into an underwriting agreement with major financial institutions including BofA Securities, Barclays Capital, Citigroup Global Markets, Deutsche Bank Securities, and Mizuho Securities USA. The offering comprised a total of $6 billion in notes with varying maturities ranging from 2027 to 2064 and interest rates from 4.500% to 5.100%. The transaction closed on February 9, 2024, with Eli Lilly netting approximately $6.45 billion after underwriting discounts and before offering expenses. The notes were issued under an existing indenture dated February 1, 1991. Eli Lilly has the option to redeem the notes at specified redemption prices and terms. The company specified that in the event of a default, the principal amount of the notes may become immediately due and payable.
2024年2月7日，制药巨头礼来公司宣布成功完成重大债券发行。该公司与包括美银证券、巴克莱资本、花旗集团环球市场、德意志银行证券和美国瑞穗证券在内的主要金融机构签订了承保协议。此次发行包括总额为60亿美元的票据，期限从2027年到2064年不等，利率从4.500％到5.100％不等。该交易于2024年2月9日完成，在承保折扣和发行费用之前，礼来公司的净收入约为64.5亿美元。这些票据是根据1991年2月1日的现有契约发行的。礼来公司可以选择按指定的兑换价格和条款兑换票据。该公司指出，如果发生违约，票据的本金可能会立即到期并支付。
2024年2月7日，制药巨头礼来公司宣布成功完成重大债券发行。该公司与包括美银证券、巴克莱资本、花旗集团环球市场、德意志银行证券和美国瑞穗证券在内的主要金融机构签订了承保协议。此次发行包括总额为60亿美元的票据，期限从2027年到2064年不等，利率从4.500％到5.100％不等。该交易于2024年2月9日完成，在承保折扣和发行费用之前，礼来公司的净收入约为64.5亿美元。这些票据是根据1991年2月1日的现有契约发行的。礼来公司可以选择按指定的兑换价格和条款兑换票据。该公司指出，如果发生违约，票据的本金可能会立即到期并支付。
有用
没用